Lionel Hutz on Liquidia's patent battle $LQDA episode artwork

EPISODE · Dec 19, 2022 · 1H 20M

Lionel Hutz on Liquidia's patent battle $LQDA

from Yet Another Value Podcast · host Andrew Walker

Lionel Hutz discusses his thesis for Liquidia (LQDA) and why the thinks they are likely to win their patent battle against United Therapeutics (UTHR). Lionel's LQDA write up: https://lionelhutz.substack.com/p/waiting-with-bated-breath-for-liquidia Chapters  0:00 Intro  2:50 LQDA overview  8:05 Diving into the patent background  16:10 Breaking down the conflicting rulings on the '793 patent  19:55 Why the PTAB ruling is the most important for '793  21:55 What's so unique about the judge's ruling on '793  28:30 Why PTAB ruled the '793 patent invalid  37:40 LQDA's primary argument for invalidating '793  43:30 Discussing the expert reports around the '793 patent  53:30 Timeline to monetization and why delaying LQDA is so important for UTHR  59:00 LQDA's upside if they win  1:13:00 LQDA's cash runway

Episode metadata supplied by the publisher feed · Published Dec 19, 2022

Embed this episode

Ready to play

Lionel Hutz on Liquidia's patent battle $LQDA

0:00 1:20:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Yet Another Value Podcast?

This episode is 1 hour and 20 minutes long.

When was this Yet Another Value Podcast episode published?

This episode was published on December 19, 2022.

Can I download this Yet Another Value Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!